20EGP
- Active ingredient
- nimodipine
- Strength
- 30 mg
- Form
- tablet
- Manufacturer
- future pharmaceutical industries (fpi)
- Route
- oral.solid
Uses
Used to improve neurological outcomes after subarachnoid hemorrhage from ruptured cerebral aneurysms.
Do not use if
Concomitant use with strong CYP3A4 inhibitors and hypersensitivity to nimodipine.
Side effects
Hypotension, headache, nausea, flushing, and dizziness may occur.
Warnings
Do not administer oral capsule contents intravenously. Monitor blood pressure carefully.
How it works
Calcium channel blocker that preferentially acts on cerebral blood vessels.
Storage
Store according to product labeling and protect from light.